Disease staging: CliniCal anD CoDeD Criteria - HCUP

Clinical Criteria with Description, Diagnostic Findings and ICD-9-CM codes
DXCat Number: MGS01
MultiStage: No
DXCat Label: Benign Prostatic Hypertrophy Specificity: A
Etiology: Degenerative
Stage Description Diagnostic findings ICD-9-CM Codes
1.01 Benign prostatic hypertrophy Benign prostatic hypertrophy [operative/pathology report or ultrasound report or physical exam report]
AND PSA < 4 ng/dl [serum chemistry report]
DX 600-60000, 6001-60010, 6002-
60020, 6009-60090 ;
1.02 with urinary tract infection Stage 1.01
AND UTI:
2.01 with bladder outlet obstruction Stage 1.01-1.02
AND bladder hypertrophy [excretory urogram report/operative cystoscopy report]
OR elevated post void residual urine [excretory urogram, ultrasound or catheterized
sample]
OR American Urological Association Symptom Index ≥ 20
2.02 with hydronephrosis Stage 1.01-2.01
AND hydronephrosis [excretory urogram or ultrasound or CT scan report]
3.01 with renal failure Stage 1.01-2.02
AND renal failure:
3.02 with sepsis Stage 1.02-3.01
AND sepsis:
3.03 with shock Stage 1.02-3.02
AND shock:
4.00 with death Stage 1.02-3.03
AND death
STAGE 1.01 + DXCAT GUS10;
DX 60001, 60011, 60021, 60091;
STAGE 1.01-1.02 + (DX 5935,
5960, 5996-59969);
STAGE 1.01-2.01 + DX 591;
STAGE 1.01-2.02 + GROUP
REN_FAIL_ACU;
STAGE 1.02-3.01 + GROUP SEPSIS;
STAGE 1.01-3.02 + (GROUP
SHOCKC OR GROUP SHOCKN) ;
NO;
References:
Anon. Benign prostatic hyperplasia: diagnosis and treatment. AHCPR. Agency for Health Care Policy and Research. J Am Geriatr Soc. 1998;46(9): 1163-5.
Darson MF, Barrett DM. Transurethral enzyme injection--future management of benign prostatic hyperplasia. Mayo Clinic Proceedings. 1998;73(9):908-11.
De Marzo AM, Nelson WG, Meeker AK, Coffey DS. Stem cell features of benign and malignant prostate epithelial cells. Journal of Urology. 1998;160(6 Pt 2):2381-92.
Hollander JB. Chapter 48 Prostate Gland disease. In: Duthie (ed). Practice of Geriatrics, 3rd ed. Philadelphia, PA: WB Saunders: 1998:535-538.
Jepsen JV. Office evaluation of men with lower urinary tract symptoms. Urol Clin North Am. 1998; 25(4): 545-54.
Presti Jr JC, Stoller ML, Carroll PR. Urology. In: Tierney Jr LM, McPhee SJ, Papadakis MA, eds. Current Medical Diagnosis & Treatment. Stamford, CT: Appleton & Lange;
1998:878-916.
Sagalowsky AI, Wilson JD. Hyperplasia and carcinoma of the prostate. In: Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL, Longo DL, eds.
Harrison's Principles of Internal Medicine, 14th ed. New York, NY: McGraw-Hill; 1998:596-602.
Stamm WE. Urinary tract infections and pyelonephritis. In: Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL, Longo DL, eds. Harrison's
Principles of Internal Medicine, 14th ed. New York, NY: McGraw-Hill; 1998:817-824.
The medical management of lower urinary tract symptoms and benign prostatic hyperplasia. Holtgrewe HL - Urol Clin North Am. 1998;25(4): 555-69.
Thursday, January 07, 2010 9:22:29 AM
©2010 Thomson Reuters. All rights reserved.